کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2485833 | 1114367 | 2011 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Î9-Tetrahydrocannabinol and Its Major Metabolite Î9-Tetrahydrocannabinol-11-oic Acid as 15-Lipoxygenase Inhibitors
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
داروسازی، سم شناسی و علوم دارویی
اکتشاف دارویی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
15-Lipoxygenase (15-LOX) is one of the key enzymes responsible for the formation of oxidized low-density lipoprotein, a major causal factor for atherosclerosis. Î9-Tetrahydrocannabinol (Î9-THC), a major component of marijuana, has suggested to suppress atherosclerosis. Although Î9-THC seems to be attractive for the prevention of atherosclerosis, there is no information about whether or not 15-LOX isoform can be inhibited by Î9-THC. In the present study, Î9-THC was found to be a direct inhibitor for 15-LOX with an IC50 (50% inhibition concentration) value of 2.42 μM. Furthermore, Î9-THC-11-oic acid, a major and nonpsychoactive metabolite of Î9-THC, but not another Î9-THC metabolite 11-OH-Î9-THC (psychoactive), was revealed to inhibit 15-LOX. Taken together, it is suggested that Î9-THC can abrogate atherosclerosis via direct inhibition of 15-LOX, and that Î9-THC-11-oic acid is shown to be an “active metabolite” of Î9-THC in this case.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Pharmaceutical Sciences - Volume 100, Issue 3, March 2011, Pages 1206-1211
Journal: Journal of Pharmaceutical Sciences - Volume 100, Issue 3, March 2011, Pages 1206-1211
نویسندگان
Shuso Takeda, Rongrong Jiang, Hironori Aramaki, Masumi Imoto, Akihisa Toda, Reiko Eyanagi, Toshiaki Amamoto, Ikuo Yamamoto, Kazuhito Watanabe,